Andere Sprachen Codexis, Inc.

Aktien

A0Q2S4

US1920051067

CDXS

Realtime-Estimate Cboe BZX Andere Börsenplätze 20:32:18 29.04.2024			% 5 Tage	% 1. Jan.
3,02 ^USD	+13,53 %		+5,77 %	-0,82 %

24.04.	Ausblick Nestlé: Organisches Wachstum im Q1 von 2,8 Prozent erwartet	AW
11.04.	Codexis, Inc. beruft Carole Cobb in seinen strategischen Beirat	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Codexis to Report First Quarter 2024 Financial Results on May 2	18.04.
Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board	11.04.
Codexis, Inc. Appoints Carole Cobb to Its Strategic Advisory Board	11.04.
Codexis: Q4 Earnings Snapshot	28.02.
Earnings Flash (CDXS) CODEXIS Reports Q4 Revenue $26.6M, vs. Street Est of $18.9M	28.02.
Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results	28.02.
Codexis, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28.02.
Codexis Shares Up 31% on Roche Licensing Agreement	27.02.
Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Roche	26.02.
Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Roche	26.02.
Codexis to Participate in TD Cowen 44th Annual Health Care Conference	26.02.
Prévisions Nestlé: croissance organique attendue à 7,3%	21.02.
Codexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory Board	20.02.
Codexis, Inc Appoints Masad Damha, PhD and Jim Lalonde, PhD to Strategic Advisory Board	20.02.
Codexis, Inc. Announces Not to Stand for Reelection of Jennifer Aaker as Board of Director	16.02.
Codexis to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 28	14.02.
Codexis, Inc. Enters into Loan and Security Agreement with Innovatus Life Sciences Lending Fund I, LP	13.02.
Codexis Secures $40 Million in Strategic Financing Deal with Innovatus Capital Partners to Further Strengthen Cash Position Ahead of Key Milestones	13.02.
Codexis, Inc. announced that it expects to receive $40 million in funding	13.02.
SeqWell and Codexis to Unveil Engineered Transposase Enzyme for Genomics Applications at AGBT General Meeting	01.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Codexis, Inc.

Aktien

A0Q2S4

US1920051067

CDXS

Andere Sprachen

Filter